Skip to content
Medical Health Aged Care

PHAA backs ban on engineered stone products

Public Health Association of Australia 2 mins read

27 October 2023

The country’s peak body for public health welcomes the release today of a Safe Work Australia report that recommends a ban on engineered stone.

Adjunct Professor Terry Slevin, CEO, Public Health Association of Australia says that although industry has tried to argue against a ban, it is necessary because safe levels of silica in engineered stone cannot be determined.

“The move to ban this common and extremely harmful product, having a disproportionate and rapid impact on people working with the extreme levels of exposure to silica in engineered stone, is well overdue.

 

“In public health we often see push back from industry when there are proposals to regulate a product that is causing significant harm. Industries often claim that the proposal is not perfect, and argue that is a reason for inaction.

 

“In the interests of protecting industry profits, commercial entities opposing health regulation will condemn more workers who use their products to catastrophic respiratory health problems. Given what we know now, that is simply wrong.

 

“If we applied the logic of these industries, we would never have made the progress we have in reducing smoking, protecting ourselves from the sun to reduce skin cancer, or in advancing road safety.

 

“There is certainly more work to be done to reduce lung diseases, including cancer, resulting from exposure to silica.

 

“Silica exposure is a health risk for people who work in construction, mining, tunnelling, roadwork, and many other industries.

“We urge all Work Health and Safety Ministers to accept the Safe Work Australia recommendation and ban the use of engineered stone in Australia.”

 

NOTE TO EDITORS: The PHAA is also signatory to a joint statement alongside the Australian Council of Trade Unions, Australian Institute of Health & Safety, Australian Institute of Occupational Hygienists, Cancer Council, Lung Foundation, and the Australian and New Zealand Society of Occupational Medicine Inc.

 

For further information/comment:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917, plord@phaa.net.au  


Contact details:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917, plord@phaa.net.au  

Media

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 01/03/2024
  • 16:07
Leukaemia Foundation / World's Greatest Shave

Barry Du Bois loses his luscious locks for a cause that’s in his blood!

Barry Du Bois has today shaved off his locks in a nod to his own journey with the blood cancer myeloma, for the Leukaemia…

  • Contains:
  • Medical Health Aged Care
  • 01/03/2024
  • 14:00
Australian Nursing and Midwifery Federation (ANMF)

ANMF Statement: Vale Linda White

The country’s largest union, the Australian Nursing and Midwifery Federation (ANMF), has been deeply saddened by the tragic death of our dear friend and Comrade, Senator Linda White. As a former Assistant Secretary of the Australian Services Union (ASU) , Linda was long-recognised for her support of working women in this country. She fiercely advocated for the implementation of paid family and domestic leave, better retirement outcomes for women and helped secure strong affirmative action targets in the ALP. Linda fought and won equal pay for 200,000 community and social services workers, securing pay rises of up to 43% for…

  • Medical Health Aged Care
  • 01/03/2024
  • 13:23
Phebra Group

Phebra Group establishes new subsidiary pharma company: ‘Phero Pharma’ will fill medical shortages in the Australian health system

Leading Australian pharmaceutical firm Phebra Group (‘Phebra’) is delighted to announce the establishment of a new subsidiary, Phero Pharma Pty Ltd (‘Phero Pharma’). Phero will focus on identifying opportunities for in-licensing of products to address pharmaceutical needs across the Australian healthcare system. “The Phebra Group is very excited about the creation of this company, Phero Pharma,” Phebra Chief Executive Officer, Andre Vlok, said today. “As an Australian-based manufacturer, Phebra has been operating in Australia for over 30 years, working closely with clinicians, hospitals, and research facilities to develop niche products, including a range of critical medicines. “Australia has long been…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.